We are preparing the requested document. Please wait, this may take a while...!
|Antigen||Vascular Endothelial Growth Factor C (VEGFC) Antibodies|
|Epitope||AA 345-390 Alternatives|
|Reactivity||Human, Mouse (Murine), Rat (Rattus) Alternatives|
|Conjugate||This VEGFC antibody is un-conjugated Alternatives|
Immunofluorescence (Paraffin-embedded Sections) (IF (p)), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Western Blotting (WB)
|3 references available|
|Supplier||Log in to see|
Product Details anti-VEGFC AntibodyTarget Details VEGFC Application Details Handling References for anti-VEGFC antibody (ABIN731723) Images
|Purification||Purified by Protein A.|
|Immunogen||KLH conjugated synthetic peptide derived from mouse VEGF-C|
|Plasmids, Primers & others|
Target Details VEGFCProduct Details anti-VEGFC Antibody Application Details Handling References for anti-VEGFC antibody (ABIN731723) Images back to top
|Alternative Name||Vegf-C (VEGFC Antibody Abstract)|
Growth factor active in angiogenesis, and endothelial cell growth, stimulating their proliferation and migration and also has effects on the permeability of blood vessels. May function in angiogenesis of the venous and lymphatic vascular systems during embryogenesis, and also in the maintenance of differentiated lymphatic endothelium in adults. Binds and activates VEGFR-2 (KDR/FLK1) and VEGFR-3 (FLT4) receptors.
Subcellular location: Secreted
Synonyms: VEGF-C, AW228853, Vascular endothelial growth factor C, Flt4 ligand, Flt4-L, Vascular endothelial growth factor-related protein, VRP, Vegfc
|Pathways||RTK Signaling, Signaling Events mediated by VEGFR1 and VEGFR2|
Application DetailsProduct Details anti-VEGFC Antibody Target Details VEGFC Handling References for anti-VEGFC antibody (ABIN731723) Images back to top
|Restrictions||For Research Use only|
HandlingProduct Details anti-VEGFC Antibody Target Details VEGFC Application Details References for anti-VEGFC antibody (ABIN731723) Images back to top
|Buffer||Aqueous buffered solution containing 1 % BSA, 50 % glycerol and 0.09 % sodium azide.|
|Precaution of Use||This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.|
|Storage Comment||Store at -20°C|
|Expiry Date||12 months|
References for anti-VEGFC antibody (ABIN731723)Product Details anti-VEGFC Antibody Target Details VEGFC Application Details Handling Images back to top
|Product cited in:||
Alunno, Ibba-Manneschi, Bistoni, Rosa, Caterbi, Gerli, Manetti: "Mobilization of lymphatic endothelial precursor cells and lymphatic neovascularization in primary Sjögren's syndrome." in: Journal of cellular and molecular medicine, Vol. 20, Issue 4, pp. 613-22, 2016 Method employed by authors: Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)) (Sample species: Human).
He, Qi, Jia, Wang, Wang, Song, Fu, Li, Luo: "Tumor cell-secreted angiogenin induces angiogenic activity of endothelial cells by suppressing miR-542-3p." in: Cancer letters, Vol. 368, Issue 1, pp. 115-25, 2015 Method employed by authors: Western Blotting (WB) (Sample species: Human).
Zhuo, Jia, Song, Lu, Ding, Wang, Song, Fu, Luo: "The CXCL12-CXCR4 chemokine pathway: a novel axis regulates lymphangiogenesis." in: Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 18, Issue 19, pp. 5387-98, 2012 Further details: Sample: mouse mammary tissue
ImagesProduct Details anti-VEGFC Antibody Target Details VEGFC Application Details Handling References for anti-VEGFC antibody (ABIN731723) back to top